MedPath

IV Acetaminophen in Children Undergoing Palatoplasty

Phase 2
Withdrawn
Conditions
Cleft Palate
Interventions
Registration Number
NCT01760330
Lead Sponsor
Nationwide Children's Hospital
Brief Summary

This project is being used to assess the utility of intravenous acetaminophen in the pediatric population undergoing palate repairs. This study is a prospective randomized double blinded placebo controlled study. The investigators will have two arms, one group of patients will receive intravenous acetaminophen and one group that will receive a placebo at a total of four doses over 24 hours. The results of this study may affect the intraoperative anesthetic management as well as post-operative surgical management of this specific patient population. The goal is to determine the benefit of adding a non-opioid analgesic and hypothesizing that it may reduce the amount of narcotic consumption in the post anesthesia care unit as well as during the post-operative stay.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • ASA physical status I or II
  • Presenting for repair of palatoplasty with Drs. Kirschner or Pearson
Exclusion Criteria
  • ASA physical status > II
  • Underlying Syndrome
  • Significant co-morbid diseases (cardiac, pulmonary, neurological disease)
  • Patients having concomitant procedures (tonsillectomy, adenoidectomy, etc.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IV acetaminophenIV acetaminophenIV acetaminophen administered q 4 hrs. for a total of 24 hrs.
PlaceboPlaceboNormal saline administered IV every 4 hrs. for a total of 24 hrs.
Primary Outcome Measures
NameTimeMethod
Pain24 hrs. post-op.

Pain scores will be assessed.

Secondary Outcome Measures
NameTimeMethod
Opioid consumption24 hrs. post-op

Trial Locations

Locations (1)

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath